Total Payments
$7,660
2024 Payments
$825.84
Companies
33
Transactions
583
Medicare Patients
2,105
Medicare Billing
$376,837
Payment Breakdown by Category
Food & Beverage$7,202 (94.0%)
Education$458.51 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,202 | 575 | 94.0% |
| Education | $458.51 | 8 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,355 | 108 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $1,002 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $845.00 | 112 | $0 (2024) |
| Allergan, Inc. | $731.63 | 73 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $643.47 | 41 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $409.82 | 20 | $0 (2024) |
| ABBVIE INC. | $356.13 | 41 | $0 (2024) |
| Lundbeck LLC | $288.40 | 18 | $0 (2024) |
| Axsome Therapeutics, Inc. | $271.39 | 11 | $0 (2024) |
| ITI, Inc. | $270.95 | 19 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $825.84 | 44 | Teva Pharmaceuticals USA, Inc. ($267.34) |
| 2023 | $1,004 | 84 | Janssen Pharmaceuticals, Inc ($227.56) |
| 2022 | $1,392 | 112 | Teva Pharmaceuticals USA, Inc. ($320.75) |
| 2021 | $1,294 | 103 | Sunovion Pharmaceuticals Inc. ($340.23) |
| 2020 | $741.48 | 54 | Sunovion Pharmaceuticals Inc. ($246.41) |
| 2019 | $957.25 | 75 | Allergan Inc. ($279.58) |
| 2018 | $796.82 | 63 | Sunovion Pharmaceuticals Inc. ($208.50) |
| 2017 | $648.67 | 48 | Sunovion Pharmaceuticals Inc. ($167.81) |
All Payment Transactions
583 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Central Nervous System | ||||||
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Neuropsychiatry | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Central Nervous System | ||||||
| 09/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: PSYCHIATRY | ||||||
| 08/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Neuroscience | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Central Nervous System | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Neuropsychiatry | ||||||
| 07/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Central Nervous System | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Education | In-kind items and services | $12.15 | General |
| Category: PSYCHIATRY | ||||||
| 05/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CNS | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 470 | 1,274 | $169,920 | $83,014 |
| 2022 | 5 | 492 | 1,322 | $182,795 | $90,825 |
| 2021 | 6 | 521 | 1,294 | $187,740 | $100,351 |
| 2020 | 5 | 622 | 1,635 | $226,200 | $102,647 |
Total Patients
2,105
Total Services
5,525
Medicare Billing
$376,837
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 620 | $83,700 | $39,772 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 198 | $31,680 | $17,452 | 55.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 125 | 315 | $31,500 | $15,699 | 49.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 32 | 127 | $19,050 | $8,312 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,990 | $1,780 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 539 | $72,765 | $35,282 | 48.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 166 | 324 | $51,840 | $27,493 | 53.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 107 | 278 | $27,800 | $14,427 | 51.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 32 | 157 | $23,550 | $10,725 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $6,840 | $2,897 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 238 | 533 | $85,280 | $47,756 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 370 | $49,950 | $25,509 | 51.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 91 | 202 | $20,200 | $10,849 | 53.7% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 28 | 137 | $20,550 | $9,625 | 46.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 34 | $6,630 | $4,507 | 68.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $5,130 | $2,104 | 41.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 260 | 699 | $111,840 | $50,709 | 45.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 209 | 534 | $53,400 | $26,373 | 49.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 236 | $31,860 | $12,387 | 38.9% |
| 90836 | Psychotherapy, 45 minutes | Office | 2020 | 28 | 138 | $20,700 | $9,338 | 45.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 28 | 28 | $8,400 | $3,840 | 45.7% |
About Dr. David Bot, MD
Dr. David Bot, MD is a Psychiatry healthcare provider based in Spokane, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1578789335.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bot, MD has received a total of $7,660 in payments from pharmaceutical and medical device companies, with $825.84 received in 2024. These payments were reported across 583 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,202).
As a Medicare-enrolled provider, Bot has provided services to 2,105 Medicare beneficiaries, totaling 5,525 services with total Medicare billing of $376,837. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Spokane, WA
- Active Since 04/18/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1578789335
Products in Payments
- LATUDA (Drug) $1,355
- VRAYLAR (Drug) $1,035
- REXULTI (Drug) $666.96
- INVEGA SUSTENNA (Drug) $631.25
- CAPLYTA (Drug) $491.62
- AUSTEDO (Drug) $422.70
- INGREZZA (Drug) $409.82
- Auvelity (Drug) $271.39
- SPRAVATO (Drug) $203.72
- ABILIFY MAINTENA (Drug) $203.71
- Austedo XR (Drug) $189.27
- ARISTADA (Drug) $141.69
- LYBALVI (Drug) $97.79
- TRINTELLIX (Drug) $93.58
- VYVANSE (Drug) $90.61
- Trintellix (Drug) $88.39
- QELBREE (Drug) $87.85
- HETLIOZ (Drug) $83.63
- Fanapt (Drug) $77.74
- BELBUCA (Drug) $52.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Spokane
John Jaccard, M.d, M.D
Psychiatry — Payments: $92,540
Psychiatry $92,540
Carl Baum, Md, MD
Psychiatry — Payments: $12,665
Psychiatry $12,665
Sandra Bremner-Dexter, Md, MD
Psychiatry — Payments: $5,840
Psychiatry $5,840
Jay Schmauch
Psychiatry — Payments: $4,030
Psychiatry $4,030
Dr. Marietta Lariosa, Md, MD
Psychiatry — Payments: $3,932
Psychiatry $3,932
Jeffrey Hedge, D.o, D.O
Psychiatry — Payments: $2,571
Psychiatry $2,571